Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check3 days agoChange DetectedThe page shows revision v3.5.4 instead of the previous revision, indicating a platform update rather than a change to the study content.SummaryDifference0.0%

- Check10 days agoChange DetectedNo additions or deletions were detected. This means the page content remains unchanged.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedNo changes detected on the page; the content and layout appear unchanged.SummaryDifference0.1%

- Check54 days agoChange DetectedNo additions or deletions detected; the page content appears unchanged.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.